First-of-its-kind, all-in-one HD-mapping and dual energy (pulsed field and radiofrequency) ablation catheter Highly anticipated by electrophysiologists for its innovation and demonstrated safety and ...

ACCESS GPO today announced a preferred, multi-year agreement with Medtronic to support availability of the Affera™ Mapping and Ablation System with Sphere-9™ Catheter in ambulatory surgery centers ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved a mapping and dual-energy catheter ablation system for treatment of persistent AF. The system ...

One-year clinical trial data for the next-generation, investigational, Sphere-360™ single-shot PFA catheter show impressive safety, performance, and efficiency results for paroxysmal Afib Dual-energy ...

GALWAY, Ireland, Jan. 23, 2026 /PRNewswire/ -- Medtronic plc (MDT), a global leader in healthcare technology, today announced two major milestones for the Affera™ Sphere-360™ catheter, a ...

Medtronic plc posted solid fiscal year second-quarter results led by the cardiovascular business with 9.3% growth. The Affera Sphere-9 pulsed field ablation system tripled the company’s sales in the ...

Access GPO has entered a multi-year agreement with Medtronic to expand ASC access to the Affera mapping and ablation system ...

It has been a week of heavy developments in one of the medical device industry’s hottest markets. From approvals to trial pauses – it has been a busy time for developers of pulsed-field ablation (PFA) ...

Abbott is joining the worldwide race to make pulsed field ablation the standard procedure for atrial fibrillation with an approval in Europe for its Volt system. Boston Scientific, Medtronic and ...

First-of-its-kind, rotation-free single-shot PFA catheter supported by strong safety and efficacy data adds to the groundbreaking Affera family of technologies in Europe Successful completion of first ...